A phase I study of belantamab mafodotin in combination with standard of care in newly diagnosed multiple myeloma: an interim analysis of DREAMM-9

被引：0

作者：

Leypoldt, L. ^{[1
]}

Usmani, S. Z. ^{[2
]}

Mielnik, M. ^{[3
]}

Byun, J. M. ^{[4
]}

Alonso, A. ^{[5
]}

Abdallah, A. -O ^{[6
]}

Garg, M. ^{[7
]}

Quach, H. ^{[8
]}

Min, C. -K ^{[9
]}

Janowski, W. ^{[10
]}

San Miguel, Ocio E. M. ^{[11
]}

Weisel, K. ^{[1
]}

Oriol, A. ^{[11
,12
,13
]}

Sandhu, I ^{[14
]}

Rodriguez-Otero, P. ^{[15
]}

Ramasamy, K. ^{[16
]}

Egger, J. L. ^{[17
]}

Williams, D. ^{[18
]}

Ma, J. ^{[19
]}

Kaisermann, M. C. ^{[18
]}

Hus, M. ^{[3
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, Lublin, Poland

[4] Seoul Natl Univ Hosp, Seoul, South Korea

[5] Hosp Quiron Madrid, Madrid, Spain

[6] Univ Kansas, US Myeloma Res Innovat Res Collaborat USMIRC, Med Ctr, Westwood, CA USA

[7] Leicester Royal rmary, Leicester, Leics, England

[8] Univ Melbourne, St Vincents Hosp Melbourne, Melbourne, Vic, Australia

[9] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[10] Calvary Mater Newcastle, Newcastle, NSW, Australia

[11] Univ Cantabria, Hosp Univ Marques Valdecilla IDIVAL, Santander, Spain

[12] Inst Catala Oncol, Badalona, Spain

[13] HUGTP, Inst Josep Carreras, Badalona, Spain

[14] Univ Alberta, Edmonton, AB, Canada

[15] Clin Univ Navarra, Dept Hematol, Pamplona, Spain

[16] Churchill Hosp, Headington, England

[17] GSK, Stevenage, Herts, England

[18] GSK, Upper Providence, PA USA

[19] GSK, Waltham, MA USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P338

引用

页码：181 / 182

页数：2